My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Española de Cirugía Oral y Maxilofacial
On-line version ISSN 2173-9161Print version ISSN 1130-0558
Abstract
GUTIERREZ-BAYARD, Lucía et al. High-dose-rate (HDR) brachytherapy in previously irradiated recurrent head and neck cancer. Rev Esp Cirug Oral y Maxilofac [online]. 2011, vol.33, n.3, pp.120-123. ISSN 2173-9161. https://dx.doi.org/10.4321/S1130-05582011000300005.
Despite advances in the treatment of head and neck cancer (HNC), 15-50% of patients present locoregional disease recurrence. The therapeutic options are limited for patients who present locally recurrent disease or a second primary tumor in a previously irradiated field. Surgical salvage with curative intent is the preferred option for patients with limited-volume disease. Re-irradiation with or without the addition of chemotherapy may hold promise for long-term survival for selected patients. High-dose-rate (HDR) brachytherapy can play an important role in the salvage treatment of previously irradiated recurrent head and neck cancer. The case reported was a 56-year old man diagnosed of tongue cancer who presented recurrent metastatic contralateral cervical node 1.5 years after radical treatment with surgery and adjuvant external radiotherapy. He received multidisciplinary treatment with chemotherapy, surgery and HDR interstitial brachytherapy.
Keywords : High-dose-rate interstitial brachytherapy; Recurrent head and neck cancer; Head and neck cancer; Re-irradiation.